3,4-Dimethoxyphenethylamine | CAS:120-20-7

We serve 3,4-Dimethoxyphenethylamine CAS:120-20-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
3,4-Dimethoxyphenethylamine

Chemical Name:3,4-Dimethoxyphenethylamine
CAS.NO:120-20-7
Synonyms:3,4-Dimethoxyphenethylamine
2-(3,4-Dimethoxyphenyl)ethanamine
3,4-Dimethoxy phenethylamine
β-(3,4-Dimethoxyphenyl)ethylamine
 
Physical and Chemical Properties:
Density 1.0±0.1 g/cm3
Boiling Point 324.1±0.0 °C at 760 mmHg
Melting Point 12-15 °C
Molecular Formula C10H15NO2
Molecular Weight 181.232
Flash Point 132.8±30.4 °C
Vapour Pressure 0.0±0.7 mmHg at 25°C
Index of Refraction 1.518
 
Specification:
Appearance:Colorless or light yellow oli liquid
Assay:≥98.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Verapamil(CAS:52-53-9).



Contact us for information like 3,4-Dimethoxyphenethylamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,β-(3,4-Dimethoxyphenyl)ethylamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,β-(3,4-Dimethoxyphenyl)ethylamine Use and application,2-(3,4-Dimethoxyphenyl)ethanamine technical grade,usp/ep/jp grade.


Related News: It is frequently associated with the presence of blasts or leukemic cells in the marrow.(-)-Dimethyl d-Tartrate manufacturer At a national conference on TCM last October, Xi urged experts and officials to carry on and innovate the fine elements in TCM and underlined efforts to promote it internationally, Xinhua reported at the time.3-Hydroxy-2'-methyl-2-naphthanilide supplier All of China’s provinces and territories have now been touched by the outbreak.1,1-Cyclobutanedimethanol vendor Pharmaceutical intermediates and APIs belong to the fine chemical industry.The purpose of APIs according to the FDA is to cause ‘pharmacological activity or other direct effects in the diagnosis, cure, mitigation, treatment or prevention of disease or to affect the structure and function of the human body.